Cancer of the Prostate and Kidney: NATO Science Series A:, cartea 53
Editat de P. H. Smithen Limba Engleză Paperback – 16 apr 2013
Din seria NATO Science Series A:
- 15% Preț: 656.58 lei
- 15% Preț: 655.13 lei
- 15% Preț: 678.35 lei
- Preț: 397.38 lei
- 5% Preț: 377.87 lei
- Preț: 397.76 lei
- 18% Preț: 1232.41 lei
- 5% Preț: 731.64 lei
- Preț: 413.15 lei
- 15% Preț: 649.22 lei
- 5% Preț: 369.45 lei
- Preț: 407.56 lei
- 5% Preț: 2162.19 lei
- Preț: 407.39 lei
- Preț: 396.40 lei
- 15% Preț: 663.93 lei
- Preț: 387.38 lei
- Preț: 393.13 lei
- Preț: 398.35 lei
- Preț: 401.24 lei
- 15% Preț: 678.81 lei
- Preț: 395.09 lei
- 18% Preț: 952.40 lei
- 15% Preț: 654.43 lei
- Preț: 402.00 lei
- Preț: 401.24 lei
- 15% Preț: 655.27 lei
- Preț: 394.71 lei
- Preț: 384.48 lei
- 5% Preț: 395.61 lei
- 5% Preț: 1421.57 lei
- 15% Preț: 651.34 lei
- Preț: 400.10 lei
- Preț: 386.99 lei
- 5% Preț: 386.11 lei
- Preț: 403.91 lei
- 15% Preț: 651.51 lei
- Preț: 393.90 lei
- 5% Preț: 376.43 lei
- Preț: 400.26 lei
- 5% Preț: 388.84 lei
- Preț: 400.65 lei
- 5% Preț: 740.58 lei
- 18% Preț: 1225.16 lei
- 5% Preț: 386.46 lei
- Preț: 421.82 lei
Preț: 405.12 lei
Preț vechi: 426.45 lei
-5% Nou
Puncte Express: 608
Preț estimativ în valută:
77.56€ • 80.92$ • 65.01£
77.56€ • 80.92$ • 65.01£
Carte tipărită la comandă
Livrare economică 13-27 martie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9781468443516
ISBN-10: 1468443518
Pagini: 776
Ilustrații: XVI, 750 p. 36 illus.
Dimensiuni: 178 x 254 x 41 mm
Greutate: 1.32 kg
Ediția:Softcover reprint of the original 1st ed. 1983
Editura: Springer Us
Colecția Springer
Seria NATO Science Series A:
Locul publicării:New York, NY, United States
ISBN-10: 1468443518
Pagini: 776
Ilustrații: XVI, 750 p. 36 illus.
Dimensiuni: 178 x 254 x 41 mm
Greutate: 1.32 kg
Ediția:Softcover reprint of the original 1st ed. 1983
Editura: Springer Us
Colecția Springer
Seria NATO Science Series A:
Locul publicării:New York, NY, United States
Public țintă
ResearchCuprins
Renal Cell Carcinoma and Carcinoma of the Prostate: Achievements and Challenges.- Prostatic Cancer: Epidemiology and Etiology.- Some Observations on Incidence and Natural History of Prostatic Carcinoma.- Animal Models in Prostatic Cancer.- Tissue Culture in Prostatic Cancer.- Histopathology of the Human Prostate Gland.- Cytology of the Prostate.- The Estimation of DNA by Absorption Cytophotometry on Smears of Trans-rectal Fine Needle Aspiration of the Prostate.- Aspiration Biopsy Cytology in the Management of Prostatic Carcinoma and in Monitoring Response to Treatment.- The Role of Aspiration Biopsy in Following Patients Treated with Chemotherapy and Radiation.- Epithelium and Stroma in Prostatic Cancer and Hyperplasia.- Grading of Prostatic Carcinoma — Evaluation of Single Parameters and Cytomorphometry.- Carcinoma of the Prostate: The Clinical Potential of Biological Markers other than Acid Phosphatase.- The Predictive Value of Serum C-Reactive Protein (CRP) Levels in Untreated Prostatic Cancer.- Immunological Detection of Prostatic Acid Phosphatase: Five Years’ Experience.- Immunological Assays for Prostatic Acid Phosphatase.- Is Determination of Prostatic Acid Phosphatase in Bone Marrow by Radioimmunoassay (BM-PAP) Useful in Patients with Prostatic Cancer?.- Studies of Acid Phosphatase in Prostatic Cancer.- The Clinical Value of the Serum Acid Phosphatase in Carcinoma of the Prostate.- Prostatic Cancer: Advances in Diagnosis.- Fine-Needle Aspiration of Soft-Tissue Masses In Prostatic Cancer Patients.- Prostatic Cancer Staging — An Overview.- Carcinoma of the Prostate — The Need for a Revision of Category TO?.- Lymph Node Metastases in Prostatic Cancer.- Lymph Node Dissection in the Management of Prostatic Cancer.- The Value of Quantified Bone Scanning in theFollow-up of Patients with Prostate Cancer and Metastatic Bone Lesions.- Pulmonary and Osseous Metastases in Prostatic Cancer: Methods of Quantitative Assessment.- The Present Status of Receptor Studies in Relation to Prostatic Cancer.- Methodology and Principles of Immuno-Cytological Assays of Steroid Receptors.- Histochemical Determination of Androgen Binding Sites in Prostatic Adenocarcinoma: Clinical Correlation.- Prostatic Cancer: Clinical Significance of Receptor Studies.- Radical Prostatectomy.- Cryosurgery of Prostatic Carcinoma.- Cryosurgical and Cryoresection Treatment of Prostatic Cancer.- Radiotherapy of Prostatic Cancer.- External Irradiation of Poorly Differentiated Prostatic Carcinoma.- Iodine-125 Implantation for Prostatic Carcinoma.- Controversial Aspects of Hormone Manipulation in Prostatic Carcinoma.- Estrogens in the Treatment of Prostatic Cancer.- Treatment of Prostatic Cancer with Diethylstilboestrol — Detection and Evaluation of the Vascular Risk.- Progestins in Prostatic Cancer.- Nolvadex (Tamoxifen), an Antioestrogen of Potential Use in the Management of Carcinoma of the Prostate.- Carcinoma of the Prostate: Adrenal Inhibitors.- Carcinoma of the Prostate — Adrenalectomy and Hypophysectomy.- Estramustine and Prednimustine.- Pepleomycin, Interferon and Estracyt in the Treatment of Poorly Differentiated Prostatic Carcinoma.- Chemotherapy of Prostatic Cancer: The National Prostatic Cancer Project Experience.- Combination of Chemotherapy with Hormones.- Strategy of Treatment in the Advanced Stages Round Table Report.- Strategy of Treatment in Prostatic Cancer — A Contribution to the Discussion.- On the Methodology of Controlled Clinical Trials.- The EORTC Phase II Studies in Advanced Prostatic Cancer.- Preliminary Results of Two EORTCRandomized Trials in Previously Untreated Patients With Advanced T3 — T4 Prostatic Cancer.- The Value of the Ancillary Factor Scoring System.- The Correlation between Grading and Clinical Response.- Criteria for Evaluating Response to Treatment in Prostatic Cancer.- Aetiology of Kidney Tumours.- Renal Cancer: In Vitro Models and Animal Tumors.- The Evaluation of Chemotherapy in a Murine Renal Adenocarcinoma.- Epidemiology of Renal Tumors.- Unrecognized Renal Cell Carcinoma.- The Use of Electron Microscopy in the Controversy of Renal Adenoma Versus Carcinoma.- Renal Oncocytoma.- Circulation Time and Renal Blood Flow In Kidney Carcinoma.- Histochemical Detection of Steroid Binding Sites in Human Renal Tissue and Renal Cell Carcinoma: A Preliminary Report of Work in Progress.- Hormone Therapy and Receptor Studies in Renal Cell Carcinoma.- Diagnostic Investigations in Renal Cancer. Advances in Diagnosis including Radiology, Lymphography, Percutaneous Puncture, Ultrasonography and Computed Tomography.- Arteriography, Venography and Radio-Isotopes in the Diagnosis of Cancer of the Kidney.- Is Arteriography Any Longer Necessary in the Assessment of Renal Cancer?.- Aspiration Biopsy and Cytology of Renal Cancer.- Dynamic Computed Tomography in Renal Tumors.- Lipid Analysis in Cystic Renal Lesions.- Cancer of the Kidney: Staging.- Histopathology and Nuclear Grading in Renal Cell Neoplasms.- Prognostic Relevance of Cytologic Grading in Metastatic Renal Cell Carcinoma.- Prognostic Factors in Renal Cancer.- Renal Cell Carcinoma: Clinical Aspects and Natural History.- Carcinoma of the Kidney: Biological Markers.- Regression of Hypernephromas.- Spontaneous Regression of Metastatic Renal Cell Carcinoma and its Significance in Assessing Response of Such Patients to Chemotherapy.-Renal Cell Carcinoma, Surgical Treatment of the Primary Lesion.- Kidney Cancer — Surgery of Metastases.- Adenocarcinoma Occurring in a Solitary Kidney.- Lymphadenectomy in Renal Cancer.- Techniques of Embolization in Renal Cancer.- How Often is Embolization of Renal Cancer Useful Nowadays?.- The Effect of Embolisation/Nephrectomy for Renal Carcinoma on the Paraneoplastic Syndromes.- Radiotherapy of Renal Cancer: Principles and Indications.- Combined Chemotherapy and Irradiation of Pulmonary Metastases in Patients with Renal Adenocarcinoma.- Preoperative Irradiation and Nephrectomy in Poorly Differentiated Carcinoma of the Kidney (A Preliminary Study).- Immunotherapy for Renal Carcinoma.- Chemotherapy of Advanced Renal Cell Carcinoma: Results of Treatment with Methyl-Glyoxal Bis-Guanylhydrazone (methyl-GAG): An EORTC Study.- 4?-epi-Adriamyein in Metastatic Renal Cell Cancer.- Is Renal Cancer a Hormone-Dependent Tumour and How Does It Respond To Hormonal Treatment? Round Table Report.- Strategy of Therapy in Renal Carcinoma — Round Table Report.- Treatment of Renal Cancer.- Renal Cancer — Clinical Studies in the U.S.A..- Conservative Management of Renal Tumours.- Speakers.